baber/WOPTO huggingface dataset:
Patent NZ-574603-A (NZ)
Title: Antimicrobial micelles for food applications
Inventor: KIRCHNER GUNTER
IPC: A23L3/3472
Filed: 2007-07-20
Abstract: Disclosed is a food composition comprising nutritional ingredients and food-grade surfactant micelles incorporating at least one antimicrobial agent, wherein the antimicrobial agent is selected from clove oil, bay oil, cinnamon oil, oregano oil, thyme oil, caraway oil, dill oil, oriander oil, citrus oil, orange oil, mustard oil or any combinations thereof. Also disclosed is the use of the above mentioned food composition for improving the microbiological safety and stability of said food composition.
Patent NZ-575765-A (NZ)
Title: New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
Inventor: BEKE GYULA
IPC: C07D277/46
Filed: 2007-10-27
Abstract: Disclosed are phenylsulfamoyl benzamide derivatives represented by general formula (I) such as 4-[2-(2,4-dichloro-phenoxy)phenylsulfamoyl]-N-{ [ (piperidin-4-ylmethyl)-carbamoyl]-methyl} -benzamide hydrochloride. Also disclosed is the use of the compounds of formula (I) for treating diseases which require the inhibition of a bradykinin receptor.
Patent NZ-578930-A (NZ)
Title: Pyridine derivatives substituted by heterocycle ring and phosphonoamino and antifungal agent containing the same
Inventor: TANAKA KEIGO
IPC: A61K31/664
Filed: 2008-04-23
Abstract: Disclosed are pyridine compounds, or salts thereof, of formula (I) wherein the pyridine ring is substituted by a heterocyclic ring and a phosphonoamino group. Also disclosed is the use of the above mentioned compounds for the manufacture of an antifungal agent.
Patent NZ-579266-A (NZ)
Title: Arrangement for cooling of an electrical machine
Inventor: BOOTH JAMES KENNETH
IPC: H02K9/04
Filed: 2009-08-26
Abstract: Arrangement for cooling an electrical machine is disclosed. The electrical machine comprises a rotor and a stator having an air-gap there-between. The stator comprises a number of stacked laminate-plates where the laminate-plates are positioned and fixed by end-plates. Slits are located between dedicated laminate-plates to allow air to pass through the laminate-plates. A joint cavity is formed by the end-plates, the central-part of the stator, the air-gap, and an the internal surface of the rotor. An air-cooling arrangement is provided which circulates air for cooling purposes inside the joint cavity. The air-cooling arrangement is connected with the stator and located within the joint cavity. The air-cooling-arrangement is arranged such that air is blown from the air-cooling-arrangement through the slits into the air-gap, passes along the internal surface of the rotor through openings of the end-plate and passes along the central-part of the stator and back to the air-cooling-arrangement.
Patent NZ-580166-A (NZ)
Title: Including access rights information in a code regarding services to which equipment is denied access
Inventor: STENFELT JOHN
IPC: G06F21/22
Filed: 2007-04-27
Abstract: Disclosed is a node (160) for use in a wireless access telecommunications system (200). The telecommunications system (200) may include a number of user equipments, UEs (110) which may send a request (1) for access to a specific service to the node (160). The node (160) is arranged to exchange information with a control function (120) in the system which holds information about the access rights to specific services for a plurality of UEs (110) in the system (200). The exchange of information is carried out over an interface between the node (160) and the control function (120). The node (160) also receives information about a UE's (110) access rights from the control function (120). The node (160) is arranged to handle access requests (1) to a service from a UE (110) by using the access rights information from said control function (120). The node (160) handles the access requests (1) using a code regarding services to which the UE (110) is denied access.
Patent NZ-580860-A (NZ)
Title: Vehicle masking cover
Inventor: BUSH STEVEN DEREK
IPC: B05B5/14
Filed: 2007-09-05
Abstract: A vehicle masking cover (10) for protecting external areas of a vehicle from overspray during a refinishing process is disclosed. The cover includes a plurality of panel sections, at least one longitudinal panel section (30) and a plurality of flank panel sections (50, 70). Each panel section (20) being provided with a fastening means (96, 98) which detachably interconnects with the fastening means (96, 98) of an adjacent panel section (20) to form a sealed seam. The at least one longitudinal panel section (30) and the plurality of flank panel sections (50, 70) are interconnected by transverse fastening means. The flank panel sections (50, 70) are detachably connected to the or each longitudinal panel section (30) by longitudinal fastening means. Adjacent flank panel sections are detachably interconnected with one another by fastening means (96, 98) which extend upwardly towards the or each longitudinal panel section (30) but which are separated from the or each longitudinal panel section (30) by a spacing. The arrangement being such that in use a flank panel section (50, 70) may be folded back from the vehicle masking cover to expose an external area of the vehicle to be refinished, while the external area of the vehicle underneath the remaining interconnected flank panel section (30) or sections (20) of the vehicle masking cover (10) is protected from overspray. The folded panel section remaining attached to the vehicle masking cover at a portion of the folded panel section containing the spacing.
Patent NZ-587215-A (NZ)
Title: Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
Inventor: KOBAYASHI KATSUMI
IPC: C07D498/04
Filed: 2009-01-21
Abstract: A tricyclic compound of formula (I') having corticotropin-releasing factor (CRF) antagonistic activity is disclosed, wherein X is a nitrogen or CRx (wherein Rx is a hydrogen or a C1-9 alkyl, provided that when X forms a double bond, Rx is absent), and wherein the other variables shown in formula (I') are as defined in the specification. These compounds are suitable for treating or preventing a disease such as disease is affective disorder, depression, anxiety or irritable bowel syndrome, which are associated with the functions of a CRF receptor.
Patent NZ-588141-A (NZ)
Title: Substituted (pyrazolylcarbonyl)imidazolidinones and their use
Inventor: THEDE KAI
IPC: A61K31/4166
Filed: 2009-03-10
Abstract: Disclosed is a (pyrazolylcarbonyl)imidazolidinone derivative of the pictured formula, where the variable substituents are as defined in the specification. Also disclosed is the use of the compound for treating retroviral diseases such as HIV.
Patent NZ-590093-A (NZ)
Title: A prestressed reinfoced concrete tilt-up wall panel formed on a profiled decking sheet
Inventor: KRALIC JOHN
IPC: E04B1/04
Filed: 2005-12-02
Abstract: 590093 A tilt-up wall panel that is formed as a separate panel and is suitable to be tilted up into a required position in use in the construction of a building and includes a composite slab that includes a profiled steel decking sheet having a cut out section which defines an opening for a window, concrete cast on the profiled decking sheet, and reinforcement embedded in the concrete.
Patent NZ-598027-A (NZ)
Title: Service dependency notification system
Inventor: BOETTNER FRED HENRY
IPC: G01F15/06
Filed: 2012-02-03
Abstract: Disclosed is a system (100) for providing notification of a service dependency. The system (100) includes at least one computing device (124) adapted to identify a dependency aware device (120). This is performed by determining whether a service dependency exists and providing a service dependency status indicator that indicates to a utility company that a dependency exists. This service dependency status indicator can be transmitted over a utility network (130).
Patent NZ-605451-A (NZ)
Title: Systems and methods for delivery of peritoneal dialysis (pd) solutions
Inventor: CLARK SPENCER C
IPC: A61M1/00
Filed: 2007-07-27
Abstract: Disclosed is a container system (10) for peritoneal dialysis (PD) solutions. The disclosure notes there is presence of degradation products in commercially available PD solutions results in damage to the peritoneal wall and can adversely affect proteins elsewhere in the body. The present container system (10) aims to reduce glucose degradation products present in PD solutions. The container system (10) comprises a first compartment (12A), a second compartment, a first frangible seal, a second frangible seal, a diffuser (18A) and a protective member (53). The first compartment (12A) contains a first PD agent (14). The second compartment contains a second PD agent. The second compartment is in any of direct and indirect fluid coupling with the first compartment (12A). A vessel (21) forms the second compartment which folds upon application of force and expels the second PD agent in connection therewith. The first frangible seal prevents fluid transfer between the first compartment (12A) and the second compartment. The second frangible seal prevents fluid transfer between the second compartment and an outlet fluid pathway (28) of the container system (10). The diffuser (18A) is in the fluid pathway between the first (12A) and second compartments and facilitates mixing of the first (14) and second PD agents. The protective member (53) inhibits breaking of the second seal prior to breaking of the first seal.
Patent NZ-605741-A (NZ)
Title: Piperidinyl compound as a modulator of chemokine receptor activity
Inventor: CHERNEY ROBERT J
IPC: A61K31/451
Filed: 2011-06-16
Abstract: The disclosure relates to (R)-N-((R)-1-((3S,4S)-4-(4-chlorophenyl)-3,4-dihydroxy-3-methylpiperidin-1-yl)-3-methyl-1-oxobutan-2-yl)-3,3-difluorocyclopentane carboxamide represented by formula (I), stereoisomers and pharmaceutically acceptable salts thereof. This compound is suitable for treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and arthrosclerosis.
Patent NZ-615477-A (NZ)
Title: Tumor necrosis factor-α humanized antibody
Inventor: ZHU BAOGUO
IPC: C12N15/63
Filed: 2012-02-13
Abstract: Disclosed is a humanised anti-TNF monoclonal antibody comprising the CDRs and FRs of the sequences as defined in the specification. Also disclosed is its use in treatment.
Patent NZ-618073-A (NZ)
Title: Medical transport device
Inventor: KOH LAWRENCE R
IPC: A61G1/04
Filed: 2012-04-12
Abstract: A medical transport device or stretcher or spinal board with facility to load or unload patient is disclosed. A spinal board, also known as a long spine board, a longboard, a spineboard or backboard, is a patient handling device used primarily during pre-hospital trauma care and is designed to provide rigid support during movement of a patient with suspected spinal or limb injuries. The spineboard (100) includes an upper panel assembly (102) having an upper panel (112) and an upper drive assembly (110) secured to a proximal end of the upper panel. A lower panel assembly (104) is detachably joined to the upper panel assembly by one or more latch assemblies (106) and one or more hinge assemblies (108). The lower panel assembly includes a lower panel (118) having a length less than a length of the upper panel assembly and a lower drive assembly (116) secured to a proximal end of the lower panel. An upper endless moveable belt (114) is wrapped about the upper panel assembly and is driven by the upper drive assembly. A lower endless moveable belt (120) is wrapped about the lower panel assembly and is driven by the lower drive assembly. The upper moveable belt and the lower moveable belt counter-rotate relative to one another. In use the distal end of the upper panel assembly of the spineboard may be positioned at the feet of the patient. When the motorized drive rollers are actuated, the upper and lower belts counter rotate relative to one another. More particularly, the lower belt moves toward the patient as it gains traction from the ground or surface where the patient lies, while the upper belt moves away from the patient, to load the patient thereon. Once the patient is loaded onto the upper panel assembly, the lower panel assembly can be detached from the upper panel assembly. As a result, the patient may be gently loaded and unloaded without lifting or manipulating the patient.
Patent NZ-631140-A (NZ)
Title: Systems and methods for statistical measurement control of spectrophotometric data
Inventor: NORRIS ALISON M
IPC: G06F17/18
Filed: 2014-01-08
Abstract: Disclosed is a computer implemented method for evaluating a coating based on its reflectance properties. The method includes obtaining, using a processor, spectral reflectance data (10) from a coated surface having a target coating theron; and determining (18), using the processor, whether the data includes any outlier data points (20). The method also includes removing (22), using the processor, datasets that contain a number of potential outliers that exceeds a threshold to produce final spectral reflectance data (32); and calculating (34), using the processor, a characteristic of the target coating based at least in part on the final spectral reflectance data.
Patent NZ-713765-A (NZ)
Title: A wireless device, network nodes and methods therein for handling a device-to-device (d2d) communication during handover in a wireless telecommunications network
Inventor: LU QIANXI
IPC: H04W72/04
Filed: 2013-05-16
Abstract: Some previous wireless telecommunications networks do not have appropriate methods for handling a D2D communication during handover of wireless device. Disclosed herein is a method performed by a first wireless device for handling a device-to-device, D2D, communication with a second wireless device, the second wireless device being served by a first network node, during handover of the first wireless device from a source network node, wherein the source network node may be the first network node or another network node, to a target network node in a wireless telecommunications network. The method comprises a step of interrupting the D2D communication. The method comprises a step of determining a first uplink timing difference as the difference between the uplink timing to the source network node and the uplink timing to the target network node. The method comprises a step of reconfiguring the D2D communication based on the first uplink timing difference. The method comprises a step of re-starting the D2D communication, as reconfigured, with the second wireless device, the second wireless device being served by the first network node after handover. The reconfiguring step further comprises transmitting the determined first uplink timing difference to the target network node after the handover has been completed and receiving a scheduling scheme for the D2D communication from the target network node, which scheduling scheme indicates time locations of sub-frames in which transmission resources may be allocated for the D2D communication.
Patent NZ-719146-A (NZ)
Title: Organic colloid-stabilized emulsion for controlling pesticide spray drift
Inventor: LIU LEI
IPC: G01N33/00
Filed: 2013-02-28
Abstract: Spray drift during the application of an aqueous mixture of an auxinic herbicide is reduced by incorporating into a spray mixture an organic colloid-stabilized oil-in-water emulsion. Disclosed is a method to reduce spray drift during the application of an aqueous pesticidal spray mixture comprising incorporating into the aqueous pesticidal spray mixture from 0.01 to 50 weight percent of an organic colloid-stabilized oil-in-water emulsion.
Patent NZ-725009-A (NZ)
Title: Formulation comprising a gemcitabine-prodrug
Inventor: GRIFFITH HUGH
IPC: A61K9/00
Filed: 2015-06-25
Abstract: This invention relates to pharmaceutical formulations of gemcitabine-[phenyl-benzoxy-L- alaninyl)]-phosphate, a monophosphate derivative of the well-known oncology drug gemcitabine. In particular, the invention relates to formulations which comprise a polar aprotic solvent, preferably dimethyl acetamide (DMA). Formulations comprising these solvent provide therapeutically effective treatments of gemcitabine-[phenyl-benzoxy-L- alaninyl)]-phosphate. The invention also relates to methods of using said formulations and kits comprising said formulations.
Patent NZ-729660-A (NZ)
Title: Flooring module
Inventor: BOYD MICHAEL DAVID
IPC: H02G3/22
Filed: 2015-09-04
Abstract: A flooring module (100) for forming a temporary access floor comprises a base component (1) defining a cruciform channel formation (3, 4) for receiving cabling or the like. The channels (3, 4) have a floor (1A) defined by the base component and a removable channel cover (2). The channel cover (2) comprises one or more channel cover components for covering the channel formation, such that the channel formation and channel cover may combine to provide a closed channel for the cabling or the like. Removal of the cover (2) allows access to the channel formation from above, in use. The sides of the base component (1) define module connector clips (20, 21) for engaging with corresponding module connector clips on adjacent modules to lock the modules together in an array. The base component (1) defines retaining formations (13, 14) for engaging with and retaining the channel cover components over the channel formation. The channel cover (2) engages against one or more of the module connector clips (20, 21) when in the clips are in the closed position so as to limit deflection of the module connector clips (20, 21) and thus prevent disengagement of the module clips from the module clips of an adjacent flooring module in an array of flooring modules. The disclosed flooring allows for swift assembly and disassembly, provides stability without the need to adhere modules to a substrate, and prevents disengagement of adjacent modules when the cover is in place.
Patent NZ-733480-A (NZ)
Title: Human antibodies to fel d1 and methods of use thereof
Inventor: MURPHY ANDREW
IPC: A61K39/395
Filed: 2013-05-02
Abstract: The present invention provides antibodies that bind to the cat allergen, Fel d1, compositions comprising the antibodies, nucleic acids encoding the antibodies and methods of use of the antibodies. According to certain embodiments of the invention, the antibodies are fully human monoclonal antibodies that bind to Fel d1. The antibodies of the invention are useful for binding to the Fel d1 allergen in vivo, thus preventing binding of the Fel d1 allergen to pre-formed IgE on the surface of mast cells or basophils. In doing so, the antibodies act to prevent the release of histamine and other inflammatory mediators from mast cells and/or basophils, thus ameliorating the untoward response to the cat allergen in sensitized individuals. The antibodies of the invention may also be useful for diagnostic purposes to determine if a patient is allergic to the Fel d1 cat allergen.
Patent NZ-737520-A (NZ)
Title: A resilient slip friction joint
Inventor: QUENNEVILLE PIERRE JOSEPH HENRI
IPC: F16F15/10
Filed: 2016-05-20
Abstract: A slip connector to connect first and second members so as to allow relative but resisted movement from an initial position due to an external forcing, and also fully return such movement back to the initial position, between the members. The connector includes a first component connectable to the first member, a second component connectable to the second member, the first and second components each having slidable ramped surfaces, and at least one resilient fixing to hold the first and second components contiguous, the contiguous interrelationship of the first and second components being of mutually ramped surfaces. The mutually slidable ramped surfaces of the two components allow for relative sliding in a first direction, under the external forcing, the relative sliding occurring oblique to the direction of a compression force of the resilient fixing, such that upon a ceasing of the external force the components are caused to return in a direction opposite the first direction to their initial position. To fully return relative movement of the first and second members, the mutually ramped surfaces are at an angle oblique to the components sufficient that, under compression force of the resilient fixings, frictional resistance between the mutually ramped surfaces is overcome.
Patent NZ-747240-A (NZ)
Title: Metal one piece locking slide and pull for slide fastener
Inventor: SHAH NIRAV
IPC: A44B19/30
Filed: 2017-03-31
Abstract: A locking slide assembly for a zipper and a method of manufacturing a locking slide assembly. The locking slide assembly has a slider (12) with a Y-shaped channel for opening and closing a zipper chain (not shown). A bridge is integrally formed to the top surface of the slider. A side surface (21) of the bridge includes a locking member channel (104) sized to locate a first end (122) of a locking member (106). A second end (108) of the locking member extends into the Y-shaped channel for engaging a portion of the zipper chain to resist unwanted movement of the slider with respect to the zipper chain. A pull member (14) having a loop portion (54) is formed as a continuous loop around the bridge of the slider. The locking slide assembly is formed in a single die cast operation within a die casting tool with at least one side shifting slide, at least one first insert, and one secondary insert (not shown), allowing the pull member to be formed in place around the bridge. The incorporation of a side shifting slide in the forming steps allows metal slide and pull assemblies to be produced in a single operation.
Patent NZ-754365-A (NZ)
Title: Novel t cell receptors and immune therapy using the same
Inventor: BUNK SEBASTIAN
IPC: A61K39/00
Filed: 2017-12-07
Abstract: The present invention pertains to antigen recognizing constructs against tumor associated antigens (MAGEA1). The invention in particular provides novel T cell receptor (TCR) based molecules which are selective and specific for the tumor expressed antigen of the invention. The TCR of the invention, and TAA binding fragments derived therefrom, are of use for the diagnosis, treatment and prevention of TAA expressing cancerous diseases. Further provided are nucleic acids encoding the antigen recognizing constructs of the invention, vectors comprising these nucleic acids, recombinant cells expressing the antigen recognizing constructs and pharmaceutical compositions comprising the compounds of the invention.
Patent NZ-757723-A (NZ)
Title: Process and apparatus for producing shaped profile sections
Inventor: RIPLEY LYNNE
IPC: B29K67/00
Filed: 2018-03-05
Abstract: The present invention provides a method for producing a shaped profile section (1) in a continuous line process, the method comprising steps of: providing an outer facing web (4), providing an inner facing web (3) and laying down an liquid foam reactants (16) in the outer facing web. Both outer and inner facing webs are preformed and the inner facing web can maintain its support without external support. An advantage of pre-forming the inner facing web is that the shaped profile section may be formed with the exact shape desired. The present invention also relates to an apparatus for producing a shaped profile section and a shaped profile section produced according to the method.